Vimian Group AB (publ) (STO:VIMIAN)

Vimian Group AB Revenue

Vimian Group AB had revenue of 120.30M EUR in the quarter ending September 30, 2026, with 15.34% growth. This brings the company's total for the last twelve months to 466.90M, up 10.90% year-over-year. In the year 2025, Vimian Group AB had annual revenue of 428.40M with 13.15% growth. That makes Vimian Group AB the 10,840th largest company in the world by revenue and 134th in Sweden.

• Revenue (ttm): 466.90M EUR
• Revenue Growth: +10.90%
• P/S Ratio: 4.23
• Revenue / Employee: 359.15K EUR
• Employees: 1,300
• Market Cap: 22.40B SEK

Revenue Chart

Chart

Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart

• Specialty Pharma 182.40M 42.9%
• Medtech 155.50M 36.6%
• Veterinary Services 64.50M 15.2%
• Diagnostics 22.90M 5.4%

By Geography

Chart

• USA 152.10M 35.8%
• Rest of the World 54.40M 12.8%
• United Kingdom of Great Britain and Northern Ireland 53.50M 12.6%
• Australia 27.00M 6.4%
• France 26.70M 6.3%
• Italy 26.50M 6.2%
• Germany 20.50M 4.8%
• Other 64.30M 15.1%

Fiscal year ended Dec 31, 2025 See the full Vimian Group AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	428.40M	49.80M	13.15%
Dec 31, 2024	378.60M	46.80M	14.10%
Dec 31, 2023	331.80M	50.49M	17.95%
Dec 31, 2022	281.31M	107.96M	62.28%
Dec 31, 2021	173.35M	102.12M	143.37%
Dec 31, 2020	71.23M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error